Investor directory

Flerie

VC fundStockholm, Swedenflerie.comLinkedIn

Flerie invests in and builds companies with pioneering pharmaceutical and biotech projects or adjacent capabilities.

What they invest in

Geographies

global

The facts

Typical cheque
€1M – €30M
Headquarters
Stockholm, Sweden
Founded
2011

Portfolio companies

More portfolio companies

A3P BiomedicalEgetis Therapeutics (STO: EGTX)Vitara BiomedicalEpiEndo PharmaceuticalsMicrobioticaProkariumSynerkine PharmaGeneos TherapeuticsAmarna TherapeuticsCobra BiologicsProvell PharmaceuticalsBuzzard PharmaceuticalsAtrogiEmpros PharmaKAHR BioAlder TherapeuticsXspray Pharma (STO: XSPRAY)Bonsai BiotherapeuticsBiosergenToleranziaNanologica (STO: NICA)Coriolis PharmaBohus (Other Devices and Supplies)Beactica Therapeutics

and 2 more

Questions founders ask

How much does Flerie typically invest?
Flerie states a typical cheque of €1M – €30M.
Which stages does Flerie invest in?
Flerie invests at Seed, Series A, Series B and Growth.
Where is Flerie based?
Flerie is headquartered in Stockholm, Sweden.

Does Flerie fit your round?

In 30 minutes you'll know which funds matter for your round.

Request access

Are you Flerie? Tell us what to correct and we will update it — or ask us to remove the entry.